CompletedNot Applicable

ICU-acquired Colonization and Infection Related to MDR in Immunocompromised Patients

France759 participantsStarted 2019-11-07

Plain-language summary

the number of immunocompromised patients hospitalized in the intensive care units (ICU) is increasing. They are at higher risk of colonization and/or infection with multi-resistant bacteria (MDR). However this risk is not well characterized. ICU acquired infections related to MDR are associated with increased morbidity and mortality. The aim of this study is to compare the incidence of ICU-acquired colonization and ICU-acquired infection related to MDR between immunocompromized and immunocompetent patients. The risk factors for ICU-acquired colonization and ICU-acquired infections, and their impact on outcome will also be evaluated and compared between immunocompromised and immunocompetent patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Expected ICU stay \> 48 hours * All patients (immunocompromised or immunocompetent). Exclusion Criteria: * Patients aged \< 18 years * Refusal to take part in the study * ICU-stay \< 48 hours * Non availability of initial MDR or subsequent screening * Participation in another study that could interfere with the risk of ICU-acquired colonization and infection with MDR bacteria

What they're measuring

Density rate of ICU-acquired infections related to MDR in immunosuppressed patients.

Timeframe: From ICU admission until day 28 after ICU admission

Trial details

NCT IDNCT04043793

SponsorUniversity Hospital, Lille

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-07

View on ClinicalTrials.gov More Immunocompromised Host trials